Rodger Tiedemann

Rodger Tiedemann

doctor New Zealand

Dr. Rodger Tiedemann is a haematologist at Auckland Hospital and an associate professor of medicine at the University of Auckland, who advocates for the funding of daratumumab, a drug that significantly improves survival rates for patients with multiple myeloma and AL amyloidosis, highlighting New Zealand's lag in providing such essential treatments.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.